A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances

Florian Weber1, Ruth Freudinger, Gerald Schwerdt

  • 1Physiologisches Institut, Universität Würzburg, Röntgenring 9, D-97070 Würzburg, Germany.

Insights

Combinations of nephrotoxins, like ochratoxin A (OTA), can alter their toxicity to kidney cells. A new method screens these effects, revealing synergistic or antagonistic impacts on cell apoptosis.

Area of Science:

  • Toxicology
  • Cell Biology
  • Renal Science

Background:

  • Simultaneous exposure to multiple nephrotoxins presents a challenge for traditional toxicity testing.
  • Understanding combined nephrotoxin effects is crucial for risk assessment.

Purpose of the Study:

  • To develop a rapid, cost-efficient method for screening the combined apoptotic potential of nephrotoxins.
  • To investigate the effects of ochratoxin A (OTA) in combination with other nephrotoxic substances on renal cells.

Main Methods:

  • Utilized a 96-well plate assay to screen the apoptotic and necrotic potential of nephrotoxin combinations.
  • Co-exposed renal epithelial cell lines to various combinations of OTA, cisplatin, cadmium, H(2)O(2), and amphotericin B.

Main Results:

  • Observed antagonistic, additive, and potentiating effects on caspase-3 activity depending on substance concentrations.
  • Co-exposure to OTA modified the apoptotic potential of other substances, with effects varying by substance, concentration, and cell line.

Conclusions:

  • Combined exposure to nephrotoxins can alter individual toxicities, potentially converting harmless substances into potent toxins or vice versa.
  • The mechanisms underlying these synergistic or antagonistic effects in renal cells require further investigation.

Related Concept Videos